Evaluating ivosidenib for the treatment of relapsed/refractory AML: design, development, and place in therapy
Samah Nassereddine,1,2 Coen J Lap,2 Imad A Tabbara1,2 1Department of Internal Medicine, The George Washington University School of Medicine, Washington, DC, USA; 2Division of Hematology/Oncology, The George Washington Cancer Center, Washington, DC, USA Abstract: Improvements in the last decade in...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2018-12-01
|
| Series: | OncoTargets and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/evaluating-ivosidenib-for-the-treatment-of-relapsedrefractory-aml-desi-peer-reviewed-article-OTT |